Background: Patients with angina symptoms and/or signs of ischemia but no obstructive
coronary artery disease (INOCA) pose a diagnostic and therapeutic challenge. Objectives …

Background—Magnetic resonance myocardial perfusion imaging (MRMPI) has a number of
advantages over the other noninvasive tests used to detect reversible myocardial ischemia …

Aims A fractional flow reserve (FFR) value≥ 0.90 after percutaneous coronary intervention
(PCI) is associated with a reduced risk of adverse cardiovascular events. TARGET-FFR is an …

Objectives The aim of this study was to test the hypothesis that invasive coronary function
testing at time of angiography could help stratify management of angina patients without …

Aims Coronary microvascular dysfunction and/or vasospasm are potential causes of
ischaemia in patients with no obstructive coronary artery disease (INOCA). We tested the …

The semiconductor industry has started the technology transition from 200mm to 300mm
wafers to improve manufacturing efficiency and reduce manufacturing cost. These …

Background: Determine the prevalence and correlates of microvascular and vasospastic
angina in patients with symptoms and signs of ischemia but no obstructive coronary artery …

Importance Microvascular obstruction commonly affects patients with acute ST-segment
elevation myocardial infarction (STEMI) and is associated with adverse outcomes. Objective …

Abstract Aims Endothelin-1 (ET-1) is a potent vasoconstrictor peptide linked to vascular
diseases through a common intronic gene enhancer [(rs9349379-G allele), chromosome 6 …

Background—Distal coronary to aortic pressure ratio (Pd/Pa) and instantaneous wave-free
ratio (iFR) are indices of functional significance of a coronary stenosis measured without …